950 — Lee's Pharmaceutical Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual income statement for Lee's Pharmaceutical Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,219	1,217	1,266	1,233	1,053
Cost of Revenue
Gross Profit	798	781	806	771	551
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,078	1,065	-712	1,157	1,009
Operating Profit	141	152	1,979	76.6	43.6
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	123	134	1,969	67.9	30.8
Provision for Income Taxes
Net Income After Taxes	63.3	78.5	1,960	45.8	19.9
Minority Interest
Net Income Before Extraordinary Items
Net Income	126	129	1,987	51.3	16.7
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	126	129	1,987	51.3	16.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.315	0.25	1.07	0.09	0.019
Dividends per Share